Submit Deal

NOVARTIS AG

HQ - Basel

Summary

Novartis International is a Swiss multinational pharmaceutical company based in Basel, and one of the largest pharmaceutical companies by both market capitalization and sales.

Deals Overview

Total Deals68

Valued Deals51

Total Value£ 98.12 B

Avg. Deal Size£ 1.92 B

Market Context

Subsidiaries

SANDOZ

6 transactions

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC

4 transactions

NOVARTIS VENTURE FUND

9 transactions

Senior Management

Liz Barrett
CEO of Novartis Oncology
Vas Narasimhan
CEO
Vasant Narasimhan
CEO

Sort

03 Aug 2017|United States|Biotechnology

Target: IFM THERAPEUTICS

Bidder: BRISTOL MYERS SQUIBB COMPANY

2 Service Providers

2 Bidder

3 Dealmakers

3 Bidder

£ 990 M

Value

08 Nov 2017|United States|Biotechnology

Target: HOMOLOGY MEDICINES INC

Bidder: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC

1 Service Providers

1 Bidder

2 Dealmakers

2 Bidder

n/a

Value

13 Nov 2017|Canada|Biotechnology

Target: PARVUS THERAPEUTICS INC

Bidder: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC

1 Service Providers

1 Bidder

2 Dealmakers

2 Bidder

n/a

Value

18 Feb 2016|United States|Biotechnology

Target: TRANSCEND MEDICAL INC

Bidder: NOVARTIS AG

1 Service Providers

1 Bidder

n/a

Value

20 Dec 2016|United States|Pharmaceuticals

Target: ENCORE VISION INC

Bidder: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC

2 Service Providers

1 Target | 1 Bidder

1 Dealmakers

1 Target

£ 373 M

Value

09 Apr 2018|United States|Biotechnology

Target: AVEXIS INC

Bidder: NOVARTIS AG

12 Service Providers

8 Target | 4 Bidder

60 Dealmakers

47 Target | 13 Bidder

£ 5.28 B

Value

30 Oct 2017|France|Biotechnology

Target: ADVANCED ACCELERATOR APPLICATIONS S.A.

Bidder: NOVARTIS AG

1 Service Providers

1 Target

1 Dealmakers

1 Target

£ 2.97 B

Value

27 Mar 2018|United Kingdom|Pharmaceuticals

Target: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LTD

Bidder: GLAXOSMITHKLINE PLC

12 Service Providers

9 Bidder | 3 Vendor

45 Dealmakers

33 Bidder | 12 Vendor

£ 9.18 B

Value

19 Jul 2018|United States|Pharmaceuticals

Target: MOR106 MONOCLONAL ANTIBODY

Bidder: NOVARTIS AG

£ 844 M

Value

18 Oct 2018|United States|Pharmaceuticals

Target: ENDOCYTE INC.

Bidder: NOVARTIS AG

6 Service Providers

5 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

n/a

Value

27 Sep 2018|China|Biotechnology

Target: CELLULAR BIOMEDICINE GROUP

Bidder: NOVARTIS AG

3 Service Providers

1 Target | 2 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 2 M

Value

20 Dec 2018|France|Biotechnology

Target: CELLFORCURE SASU

Bidder: NOVARTIS AG

2 Service Providers

1 Bidder | 1 Vendor

2 Dealmakers

1 Bidder | 1 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy